Table 1 Patient’s characteristics with CMI or PAOD and their characteristics when classified as well-controlled (HbA1c ≤ 6.5) or poorly-controlled (HbA1c > 6.5) diabetic patients
| Â | Â | Â | PAOD Subjects | Â |
|---|---|---|---|---|
|  | CMI Subjects | PAOD Subjects | DM2 with HbA1c ≤ 6.5 | DM2 with HbA1c > 6.5 |
N (%) | 5 (25.0) | 15 (75.0) | 6 (40.0) | 9 (60.0) |
Age (years) | 63.2 ± 13.0 | 67.3 ± 14.2 | 73.8 ± 11.8 | 63.0 ± 14.6 |
Sex (Male/Female) (%) | 5/0 | 12/3 | 5 (83.3)/2 (16.7) | 7 (77.8)/2 (22.2) |
Weight (Kg) | 75.9 ± 10.1 | 68.7 ± 12.1 | 63.5 ± 11.3 | 72.1 ± 11.9 |
Waist circumference (cm) | 94.5 ± 3.5 | 96.7 ± 8.7 | 96.5 ± 12.7 | 90.8 ± 19.2 |
BMI (kg/m2) | 27.9 ± 3.5 | 25.3 ± 3.9 | 24.6 ± 4.4 | 25.7 ± 3.7 |
SBP/DBP (mmHg) | 133/74 ± 24/14 | 150/76 ± 24/13 | 141/78 ± 21/6 | 155/75 ± 26/16 |
Glycemia (mg/dL) | 105.2 ± 8.3 | 129.2 ± 48.1 | 96.2 ± 31.1 | 151.2 ± 32.6* |
HbA1c (%) | 6.2 ± 0.3 | 7.8 ± 1.8 | 6.0 ± 0.4 | 8.9 ± 1.3** |
Creatinine (mg/dL) | 1.0 ± 0.3 | 1.9 ± 0.9 | 1.2 ± 0.7 | 2.5 ± 1.7 |
Uric acid (mg/dL) | 5.4 ± 1.4 | 4.5 ± 2.8 | 3.6 ± 2.0 | 5.3 ± 3.3 |
Total cholesterol (mg/dL) | 135.8 ± 37.9 | 152.7 ± 55.6 | 126.5 ± 67.0 | 179.9 ± 61.1 |
LDL cholesterol (mg/dL) | 81.8 ± 15.5 | 88.0 ± 28.12 | 73.4 ± 21.7 | 112.4 ± 52.2 |
HDL cholesterol (mg/dL) | 32.4 ± 12.0 | 32.6 ± 13.8 | 32.3 ± 18.9 | 32.9 ± 9.0 |
Triglycerides (mg/dL) | 201.0 [106.0-302.0] | 122.0 [82.3-234.5] | 116.5 [74.8-131.5] | 210.5 [83.5-364.3] |
GOT (U/l) | 27.2 ± 9.8 | 34.23 ± 9.3 | 40.8 ± 46.5 | 28.6 ± 19.7 |
GPT(U/l) | 53.2 ± 30.0 | 40.7 ±19.0 | 42.5 ± 20.5 | 39.1 ± 19.1 |
GGT (U/l) | 30.2 ± 9.8 | 56.1 ± 7.1 | 89.3 ± 40.7 | 114.6 ± 132.8 |
Insulin (μUI/ml) | 13.5 ± 9.3 | 11.8 ± 6.4 | 10.5 ± 5.8 | 12.6 ± 7.3 |
HOMA index | 5.9 ± 4.6 | 4.1 ± 2.2 | 2.8 ± 1.6 | 5.3 ± 2.4 |
Hypertension (%) | 21.4 | 73.3 | 66.7 | 77.8 |
Dyslipidemia (%) | 57.1 | 85.7 | 83.3 | 87.5 |
Obesity (%) | 16.7 | 33.3 | 33.3 | 33.3 |
Smoker (%) | 33.3 | 13.3 | 11.1 | 22.2 |